138 related articles for article (PubMed ID: 2899964)
21. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
[TBL] [Abstract][Full Text] [Related]
22. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
[TBL] [Abstract][Full Text] [Related]
23. [The purification and application of Epstein-Barr virus gp125].
Wang G; Pi G; Gu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
[TBL] [Abstract][Full Text] [Related]
24. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
25. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
Takimoto T; Sato H; Ogura H; Glaser R
Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
[TBL] [Abstract][Full Text] [Related]
26. A novel early antigen associated with Epstein-Barr virus productive cycle.
Freemer CS; Bertoni G; Takagi S; Sairenji T
Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
28. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
29. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
30. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
Ito Y; Kishishita M; Yanase S
Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
[TBL] [Abstract][Full Text] [Related]
31. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
Prachová K
Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
[No Abstract] [Full Text] [Related]
33. Expression of viral capsid protein antigen against Epstein-Barr virus in plastids of Nicotiana tabacum cv. SR1.
Lee MY; Zhou Y; Lung RW; Chye ML; Yip WK; Zee SY; Lam E
Biotechnol Bioeng; 2006 Aug; 94(6):1129-37. PubMed ID: 16586511
[TBL] [Abstract][Full Text] [Related]
34. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Coker-Vann M; Dolin R
J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
[TBL] [Abstract][Full Text] [Related]
35. The biological activity of hydrogen peroxide. III. Induction of Epstein-Barr virus via indirect action, as compared with TPA and teleocidin.
Oya Y; Tonomura A; Yamamoto K
Int J Cancer; 1987 Jul; 40(1):69-73. PubMed ID: 3036721
[TBL] [Abstract][Full Text] [Related]
36. Activation of Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells with propionic acid and with culture fluids of propionic acid-producing anaerobes.
Kishishita M; Yanase S; Ito Y
Cancer Lett; 1982; 16(2):117-20. PubMed ID: 6290028
[TBL] [Abstract][Full Text] [Related]
37. Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection.
Moar MH; Klein G
Intervirology; 1980; 13(3):178-85. PubMed ID: 6246034
[TBL] [Abstract][Full Text] [Related]
38. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of 1-beta-D-arabinofuranosylthymine on synthesis of Epstein-Barr virus.
Yonemura K; Sairenji T; Hinuma Y
Microbiol Immunol; 1981; 25(6):557-63. PubMed ID: 6268944
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus early antigen induction in Raji cells by Chinese medicinal herbs.
Zeng Y; Zhong JM; Mo YK; Miao XC
Intervirology; 1983; 19(4):201-4. PubMed ID: 6305871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]